Literature DB >> 17101265

In vitro effects of micafungin against Candida biofilms on polystyrene and central venous catheter sections.

Marc Seidler1, Stefanie Salvenmoser, Frank-Michael C Müller.   

Abstract

Long-term inserted and surgically implanted catheters can be colonised by Candida spp. Candida biofilms in vitro are often resistant to antifungal agents. The aim of this study was to investigate the in vitro activity of micafungin (MFG) against six Candida spp. biofilms on polystyrene (PS) and central venous catheter (CVC) sections. Safranin staining and differential interference contrast microscopy were used to demonstrate biofilm production. MFG activity was determined by the reduction in metabolic activity (%RMA) by tetrazolium reduction assay on both substrates. In vitro, Candida albicans, Candida parapsilosis, Candida glabrata, Candida tropicalis, Candida dubliniensis and Candida kefyr produced mature biofilms on PS and CVC sections. MFG was active against C. kefyr (0.5 microg/mL) and C. glabrata (<0.5 microg/mL) on PS. However, MFG displayed resistance (>16 microg/mL) against C. albicans, C. dubliniensis,C. tropicalis and C. parapsilosis. On CVC disks, MFG was active against C. glabrata (1 microg/mL) as well as C. parapsilosis and C. albicans (<0.5 microg/mL). MFG was resistant (>16 microg/mL) against C. dubliniensis, C. tropicalis and C. kefyr. MFG was active in vitro against all six Candida spp. on both substrates. However, MFG could not reduce the metabolic activity completely even at the highest concentration.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17101265     DOI: 10.1016/j.ijantimicag.2006.07.024

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN: 0924-8579            Impact factor:   5.283


  16 in total

1.  E1210, a new broad-spectrum antifungal, suppresses Candida albicans hyphal growth through inhibition of glycosylphosphatidylinositol biosynthesis.

Authors:  Nao-Aki Watanabe; Mamiko Miyazaki; Takaaki Horii; Koji Sagane; Kappei Tsukahara; Katsura Hata
Journal:  Antimicrob Agents Chemother       Date:  2011-12-05       Impact factor: 5.191

Review 2.  Micafungin: A Review in the Prophylaxis and Treatment of Invasive Candida Infections in Paediatric Patients.

Authors:  Lesley J Scott
Journal:  Paediatr Drugs       Date:  2017-02       Impact factor: 3.022

3.  Micafungin at physiological serum concentrations shows antifungal activity against Candida albicans and Candida parapsilosis biofilms.

Authors:  M Guembe; J Guinea; L J Marcos-Zambrano; A Fernández-Cruz; T Peláez; P Muñoz; E Bouza
Journal:  Antimicrob Agents Chemother       Date:  2014-06-23       Impact factor: 5.191

Review 4.  Micafungin: a review of its use in the prophylaxis and treatment of invasive Candida infections in pediatric patients.

Authors:  Natalie J Carter; Gillian M Keating
Journal:  Paediatr Drugs       Date:  2009       Impact factor: 3.022

5.  Self-induction of a/a or alpha/alpha biofilms in Candida albicans is a pheromone-based paracrine system requiring switching.

Authors:  Song Yi; Nidhi Sahni; Karla J Daniels; Kevin L Lu; Guanghua Huang; Thyagarajan Srikantha; David R Soll
Journal:  Eukaryot Cell       Date:  2011-04-15

6.  Anticandidal efficacy of cinnamon oil against planktonic and biofilm cultures of Candida parapsilosis and Candida orthopsilosis.

Authors:  Regina Helena Pires; Lilian Bueno Montanari; Carlos Henrique G Martins; José Eduardo Zaia; Ana Marisa Fusco Almeida; Marcelo T Matsumoto; Maria José S Mendes-Giannini
Journal:  Mycopathologia       Date:  2011-07-15       Impact factor: 2.574

7.  Species-specific and drug-specific differences in susceptibility of Candida biofilms to echinocandins: characterization of less common bloodstream isolates.

Authors:  Maria Simitsopoulou; Pavla Peshkova; Efthymia Tasina; Aspasia Katragkou; Daniela Kyrpitzi; Aristea Velegraki; Thomas J Walsh; Emmanuel Roilides
Journal:  Antimicrob Agents Chemother       Date:  2013-03-25       Impact factor: 5.191

Review 8.  Micafungin: a review of its use in adults for the treatment of invasive and oesophageal candidiasis, and as prophylaxis against Candida infections.

Authors:  Sarah A Cross; Lesley J Scott
Journal:  Drugs       Date:  2008       Impact factor: 9.546

9.  Aspergillus fumigatus forms biofilms with reduced antifungal drug susceptibility on bronchial epithelial cells.

Authors:  Marc J Seidler; Stefanie Salvenmoser; Frank-Michael C Müller
Journal:  Antimicrob Agents Chemother       Date:  2008-08-18       Impact factor: 5.191

10.  Property differences among the four major Candida albicans strain clades.

Authors:  Donna M MacCallum; Luis Castillo; Kerstin Nather; Carol A Munro; Alistair J P Brown; Neil A R Gow; Frank C Odds
Journal:  Eukaryot Cell       Date:  2009-01-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.